2025-08-21 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
2,577,043 |
9,680,185 |
|
|
|
2025-08-14 |
13D/A
|
|
|
|
255,750 |
|
|
|
2025-08-14 |
13G/A
|
OKUR / OnKure Therapeutics, Inc.
|
|
1,004,439 |
0 |
|
|
|
2025-08-14 |
13G/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
6,395,546 |
4,639,949 |
|
|
|
2025-08-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
21,464,527 |
7,412,830 |
|
|
|
2025-08-14 |
13G/A
|
CTNM / Contineum Therapeutics, Inc.
|
|
1,441,249 |
699,486 |
|
|
|
2025-08-14 |
13G/A
|
EOLS / Evolus, Inc.
|
|
4,129,142 |
2,474,843 |
|
|
|
2025-08-14 |
13G/A
|
AVR / Anteris Technologies Global Corp.
|
|
2,440,000 |
1,705,130 |
|
|
|
2025-08-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
4,875,851 |
4,051,631 |
|
|
|
2025-08-14 |
13G/A
|
ACLX / Arcellx, Inc.
|
|
2,926,478 |
2,478,000 |
|
|
|
2025-08-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
6,565,933 |
5,507,591 |
|
|
|
2025-08-07 |
13G/A
|
BBNX / Beta Bionics, Inc.
|
|
2,203,840 |
1,593,608 |
|
|
|
2025-08-04 |
13G
|
CELC / Celcuity Inc.
|
|
2,362,279 |
2,670,597 |
|
|
|
2025-08-04 |
13G/A
|
CELC / Celcuity Inc.
|
|
2,362,279 |
1,633,208 |
|
|
|
2025-07-22 |
13G
|
PRAX / Praxis Precision Medicines, Inc.
|
|
980,894 |
1,362,503 |
|
|
|
2025-06-24 |
13D/A
|
NAUT / Nautilus Biotechnology, Inc.
|
|
12,594,211 |
12,815,113 |
|
|
|
2025-06-04 |
13G/A
|
ACRV / Acrivon Therapeutics, Inc.
|
|
3,104,139 |
0 |
|
|
|
2025-05-15 |
13G/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
5,435,210 |
4,423,441 |
|
|
|
2025-05-15 |
13G/A
|
TRAW / Traws Pharma, Inc.
|
|
386,555 |
545,197 |
|
|
|
2025-05-15 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
22,112,266 |
12,808,788 |
|
|
|
2025-05-15 |
13G/A
|
TIL / Instil Bio, Inc.
|
|
345,545 |
0 |
|
|
|
2025-05-15 |
13G
|
BDSX / Biodesix, Inc.
|
|
6,673,880 |
7,673,880 |
|
|
|
2025-05-15 |
13G/A
|
OM / Outset Medical, Inc.
|
|
|
1,208,334 |
|
|
|
2025-05-15 |
13G/A
|
ENSC / Ensysce Biosciences, Inc.
|
|
86,666 |
86,666 |
|
|
|
2025-05-15 |
13G/A
|
EOLS / Evolus, Inc.
|
|
5,356,622 |
4,129,142 |
|
|
|
2025-05-15 |
13G/A
|
EWTX / Edgewise Therapeutics, Inc.
|
|
5,164,487 |
6,395,546 |
|
|
|
2025-05-15 |
13G/A
|
SRZN / Surrozen, Inc.
|
|
166,666 |
166,666 |
|
|
|
2025-05-15 |
13G/A
|
ACLX / Arcellx, Inc.
|
|
3,888,669 |
2,926,478 |
|
|
|
2025-05-15 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
1,829,735 |
980,894 |
|
|
|
2025-05-15 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
24,245,952 |
21,464,527 |
|
|
|
2025-05-15 |
13G/A
|
CTNM / Contineum Therapeutics, Inc.
|
|
1,441,249 |
1,441,249 |
|
|
|
2025-05-15 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
4,731,150 |
1,481,481 |
|
|
|
2025-05-15 |
13G
|
BBNX / Beta Bionics, Inc.
|
|
|
2,203,840 |
|
|
|
2025-05-15 |
13G/A
|
DRUG / Bright Minds Biosciences Inc.
|
|
430,000 |
444,649 |
|
|
|
2025-05-15 |
13G/A
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
6,774,348 |
7,874,348 |
|
|
|
2025-05-01 |
13G/A
|
ACRV / Acrivon Therapeutics, Inc.
|
|
5,360,858 |
3,104,139 |
|
|
|
2025-04-23 |
13G/A
|
CRGX / CARGO Therapeutics, Inc.
|
|
3,436,600 |
1,170,810 |
|
|
|
2025-04-07 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
9,275,851 |
4,875,851 |
|
|
|
2025-04-03 |
13G/A
|
ENSC / Ensysce Biosciences, Inc.
|
|
86,666 |
86,666 |
|
|
|
2025-03-31 |
13G
|
IRD / Opus Genetics, Inc.
|
|
|
4,510,501 |
|
|
|
2025-03-26 |
13G
|
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
|
5,555,555 |
|
|
|
2025-03-25 |
13D/A
|
TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock)
|
|
85,800,000 |
85,800,000 |
|
|
|
2025-02-28 |
13G
|
OM / Outset Medical, Inc.
|
|
1,863,397 |
5,625,000 |
|
|
|
2025-02-21 |
13G
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
5,164,487 |
|
|
|
2025-02-21 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
6,934,678 |
11,934,679 |
|
|
|
2025-02-14 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
26,617,709 |
22,112,266 |
|
|
|
2025-02-14 |
13G/A
|
ADGM / Adagio Medical Holdings, Inc.
|
|
15,257,488 |
15,321,655 |
|
|
|
2025-02-14 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
7,962,147 |
4,731,150 |
|
|
|
2025-02-14 |
13G/A
|
PRAX / Praxis Precision Medicines, Inc.
|
|
1,119,035 |
1,829,735 |
|
|
|
2025-02-14 |
13G
|
AVR / Anteris Technologies Global Corp.
|
|
|
2,440,000 |
|
|
|
2025-02-14 |
13G/A
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
4,458,741 |
6,774,348 |
|
|
|
2025-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
28,057,456 |
24,245,952 |
|
|
|
2025-02-14 |
13G/A
|
CELC / Celcuity Inc.
|
|
1,481,300 |
2,362,279 |
|
|
|
2025-02-14 |
13G/A
|
SYRE / Spyre Therapeutics, Inc.
|
|
2,872,547 |
2,574,723 |
|
|
|
2025-02-14 |
13G/A
|
CTNM / Contineum Therapeutics, Inc.
|
|
1,566,669 |
1,441,249 |
|
|
|
2025-02-14 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
151,433 |
163,935 |
|
|
|
2025-02-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
2,139,950 |
5,880,000 |
|
|
|
2025-02-14 |
13G/A
|
BDSX / Biodesix, Inc.
|
|
6,673,880 |
6,673,880 |
|
|
|
2025-02-14 |
13G/A
|
ENSC / Ensysce Biosciences, Inc.
|
|
1,300,000 |
86,666 |
|
|
|
2025-02-14 |
13G/A
|
APLT / Applied Therapeutics, Inc.
|
|
10,005,000 |
2,860,000 |
|
|
|
2025-02-14 |
13G
|
SRZN / Surrozen, Inc.
|
|
|
166,666 |
|
|
|
2025-02-14 |
13D/A
|
TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock)
|
|
56,000,000 |
85,800,000 |
|
|
|
2025-01-31 |
13D/A
|
NAUT / Nautilus Biotechnology, Inc.
|
|
12,594,211 |
12,594,211 |
|
|
|
2025-01-08 |
13G
|
TRAW / Traws Pharma, Inc.
|
|
|
386,555 |
|
|
|
2024-12-16 |
13D/A
|
LYRA / Lyra Therapeutics, Inc.
|
|
12,757,562 |
12,757,562 |
|
|
|
2024-12-09 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
7,099,182 |
7,962,147 |
|
|
|
2024-11-19 |
13D/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
3,454,976 |
1,770,792 |
|
|
|
2024-11-14 |
13G
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
5,143,575 |
5,435,210 |
|
|
|
2024-11-14 |
13G
|
INBX / Inhibrx Biosciences, Inc.
|
|
1,968,744 |
1,488,553 |
|
|
|
2024-11-14 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
6,925,028 |
6,934,678 |
|
|
|
2024-11-14 |
13D/A
|
TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock)
|
|
56,000,000 |
56,000,000 |
|
|
|
2024-11-14 |
13G/A
|
INBX.V / Inhibrx, Inc.
|
|
4,776,306 |
0 |
|
|
|
2024-11-14 |
13G/A
|
APLT / Applied Therapeutics, Inc.
|
|
4,580,249 |
10,005,000 |
|
|
|
2024-11-14 |
13G/A
|
EOLS / Evolus, Inc.
|
|
3,963,424 |
5,356,622 |
|
|
|
2024-11-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
5,118,145 |
6,565,933 |
|
|
|
2024-11-14 |
13G/A
|
NUVL / Nuvalent, Inc.
|
|
2,917,991 |
2,979,235 |
|
|
|
2024-11-14 |
13G/A
|
DTIL / Precision BioSciences, Inc.
|
|
500,000 |
426,293 |
|
|
|
2024-11-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
8,593,586 |
9,275,851 |
|
|
|
2024-11-14 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
19,221,743 |
26,617,709 |
|
|
|
2024-11-14 |
13G/A
|
VRDN / Viridian Therapeutics, Inc.
|
|
4,022,066 |
2,812,665 |
|
|
|
2024-11-14 |
13G/A
|
NVNO / enVVeno Medical Corporation
|
|
1,394,716 |
1,869,219 |
|
|
|
2024-11-14 |
13D/A
|
ATXS / Astria Therapeutics, Inc.
|
|
6,485,420 |
6,485,420 |
|
|
|
2024-11-14 |
13G/A
|
SYRE / Spyre Therapeutics, Inc.
|
|
2,606,679 |
2,872,547 |
|
|
|
2024-11-14 |
13D/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
3,074,542 |
3,454,976 |
|
|
|
2024-11-14 |
13G/A
|
ACLX / Arcellx, Inc.
|
|
4,544,809 |
3,888,669 |
|
|
|
2024-11-14 |
13D/A
|
NAUT / Nautilus Biotechnology, Inc.
|
|
12,594,211 |
12,594,211 |
|
|
|
2024-11-14 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
3,633,635 |
151,433 |
|
|
|
2024-11-13 |
13G
|
ADGM / Adagio Medical Holdings, Inc.
|
|
|
15,257,488 |
|
|
|
2024-10-31 |
13D/A
|
ATHA / Athira Pharma, Inc.
|
|
5,458,448 |
5,479,348 |
|
|
|
2024-10-29 |
13G
|
ENSC / Ensysce Biosciences, Inc.
|
|
|
1,300,000 |
|
|
|
2024-10-25 |
13G
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
1,869,125 |
4,458,741 |
|
|
|
2024-10-22 |
13G
|
IKT / Inhibikase Therapeutics, Inc.
|
|
|
6,799,944 |
|
|
|
2024-10-17 |
13D/A
|
IMTX / Immatics N.V.
|
|
8,170,846 |
9,469,705 |
|
|
|
2024-10-16 |
13G
|
DRUG / Bright Minds Biosciences Inc.
|
|
|
430,000 |
|
|
|
2024-10-10 |
13G
|
OKUR / OnKure Therapeutics, Inc.
|
|
|
1,004,439 |
|
|
|
2024-09-27 |
13G
|
TIL / Instil Bio, Inc.
|
|
|
345,545 |
|
|
|
2024-09-24 |
13D/A
|
VAPO / Vapotherm, Inc.
|
|
2,012,999 |
1,000 |
|
|
|
2024-09-23 |
13G
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
1,119,035 |
|
|
|
2024-08-15 |
13D/A
|
LYRA / Lyra Therapeutics, Inc.
|
|
12,757,563 |
12,757,562 |
|
|
|
2024-08-14 |
13D/A
|
MGTX / MeiraGTx Holdings plc
|
|
11,442,562 |
12,696,562 |
|
|
|
2024-07-29 |
13G
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
3,866,214 |
5,118,145 |
|
|
|
2024-07-17 |
13G/A
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
2,432,089 |
4,592,556 |
|
|
|
2024-06-25 |
13D
|
VAPO / Vapotherm, Inc.
|
|
0 |
2,012,999 |
|
|
|
2024-06-06 |
13D
|
IMTX / Immatics N.V.
|
|
|
8,170,846 |
|
|
|
2024-05-13 |
13G
|
BDSX / Biodesix, Inc.
|
|
|
6,673,880 |
|
|
|
2024-05-01 |
13D/A
|
TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock)
|
|
56,000,000 |
56,000,000 |
|
|
|
2024-04-17 |
13D/A
|
VBIVQ / VBI Vaccines Inc.
|
|
1,381,355 |
1,261,710 |
|
|
|
2024-04-17 |
13D/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
3,268,579 |
5,143,575 |
|
|
|
2024-04-15 |
13G
|
CTNM / Contineum Therapeutics, Inc.
|
|
|
1,566,669 |
|
|
|
2024-04-15 |
13G/A
|
ACRV / Acrivon Therapeutics, Inc.
|
|
3,007,858 |
5,360,858 |
|
|
|
2024-04-10 |
13D/A
|
LABP / Landos Biopharma, Inc.
|
|
14,869,915 |
1,486,991 |
|
|
|
2024-04-03 |
13D/A
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
3,268,579 |
3,268,579 |
|
|
|
2024-03-20 |
13D
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
3,260,013 |
3,268,579 |
|
|
|
2024-03-14 |
13G
|
DTIL / Precision BioSciences, Inc.
|
|
|
500,000 |
|
|
|
2024-03-11 |
13G
|
AORT / Artivion, Inc.
|
|
|
2,383,978 |
|
|
|
2024-03-06 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
2,099,952 |
0 |
|
|
|
2024-03-01 |
13D/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
5,333,532 |
1,488,703 |
|
|
|
2024-03-01 |
13G
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
11,979,415 |
19,221,743 |
|
|
|
2024-02-29 |
13D/A
|
LIANY / LianBio - Depositary Receipt (Common Stock)
|
|
|
57,850,841 |
|
|
|
2024-02-23 |
13G/A
|
NVNO / enVVeno Medical Corporation
|
|
1,394,716 |
1,394,716 |
|
|
|
2024-02-14 |
13G/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
2,483,619 |
0 |
|
|
|
2024-02-14 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
3,627,775 |
3,633,635 |
|
|
|
2024-02-14 |
13G/A
|
APLT / Applied Therapeutics, Inc.
|
|
4,580,249 |
4,580,249 |
|
|
|
2024-02-14 |
13G/A
|
INBX.V / Inhibrx, Inc.
|
|
3,313,783 |
4,776,306 |
|
|
|
2024-02-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
8,593,586 |
8,593,586 |
|
|
|
2024-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
11,900,255 |
6,433,369 |
|
|
|
2024-02-14 |
13G/A
|
BLPH / Bellerophon Therapeutics, Inc.
|
|
930,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
ACLX / Arcellx, Inc.
|
|
2,598,305 |
4,544,809 |
|
|
|
2024-02-14 |
13G/A
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
2,432,089 |
2,432,089 |
|
|
|
2024-02-14 |
13G/A
|
LRMR / Larimar Therapeutics, Inc.
|
|
2,860,000 |
0 |
|
|
|
2024-02-14 |
13G/A
|
CBAY / CymaBay Therapeutics, Inc.
|
|
5,278,962 |
4,024,400 |
|
|
|
2024-02-14 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
5,038,983 |
7,099,182 |
|
|
|
2024-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
4,511,275 |
1,074,807 |
|
|
|
2024-02-14 |
13G/A
|
CRGX / CARGO Therapeutics, Inc.
|
|
3,246,168 |
3,436,600 |
|
|
|
2024-02-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
1,798,955 |
2,139,950 |
|
|
|
2024-02-14 |
13G/A
|
LPTX / Leap Therapeutics, Inc.
|
|
6,726,496 |
1,068,497 |
|
|
|
2024-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
27,642,917 |
28,057,456 |
|
|
|
2024-02-14 |
13G/A
|
NVNO / enVVeno Medical Corporation
|
|
937,515 |
1,394,716 |
|
|
|
2024-02-14 |
13D/A
|
MGTX / MeiraGTx Holdings plc
|
|
11,406,563 |
11,442,562 |
|
|
|
2024-02-14 |
13G/A
|
ACRV / Acrivon Therapeutics, Inc.
|
|
3,007,858 |
3,007,858 |
|
|
|
2024-02-14 |
13G/A
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
6,088,333 |
1,869,125 |
|
|
|
2024-02-14 |
13G/A
|
CELC / Celcuity Inc.
|
|
1,441,300 |
1,481,300 |
|
|
|
2024-02-14 |
13G/A
|
EOLS / Evolus, Inc.
|
|
3,086,604 |
3,963,424 |
|
|
|
2024-02-14 |
13G/A
|
VERU / Veru Inc.
|
|
7,858,011 |
5,584,699 |
|
|
|
2024-02-14 |
13D/A
|
LYRA / Lyra Therapeutics, Inc.
|
|
12,757,563 |
12,757,563 |
|
|
|
2024-02-14 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
9,971,780 |
11,979,415 |
|
|
|
2024-02-14 |
13G/A
|
SYRE / Spyre Therapeutics, Inc.
|
|
2,606,679 |
2,606,679 |
|
|
|
2024-02-14 |
13G/A
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
4,462,666 |
3,866,214 |
|
|
|
2024-02-12 |
13G
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
3,260,013 |
|
|
|
2024-02-09 |
13D
|
TRIB / Trinity Biotech plc - Depositary Receipt (Common Stock)
|
|
|
56,000,000 |
|
|
|
2024-02-05 |
13D/A
|
ATXS / Astria Therapeutics, Inc.
|
|
3,627,693 |
6,485,420 |
|
|
|
2024-01-29 |
13G
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
4,022,066 |
|
|
|
2024-01-19 |
13G
|
FUSN / Fusion Pharmaceuticals Inc.
|
|
|
4,737,194 |
|
|
|
2024-01-12 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
3,501,265 |
6,925,028 |
|
|
|
2024-01-02 |
13G
|
NUVL / Nuvalent, Inc.
|
|
|
2,917,991 |
|
|
|
2023-12-29 |
13D/A
|
ATHA / Athira Pharma, Inc.
|
|
4,811,149 |
5,458,448 |
|
|
|
2023-12-26 |
13G
|
CELC / Celcuity Inc.
|
|
|
1,441,300 |
|
|
|
2023-12-13 |
13G
|
SYRE / Spyre Therapeutics, Inc.
|
|
|
2,606,679 |
|
|
|
2023-12-06 |
13G
|
APLT / Applied Therapeutics, Inc.
|
|
|
4,580,249 |
|
|
|
2023-11-27 |
13G
|
EOLS / Evolus, Inc.
|
|
|
3,086,604 |
|
|
|
2023-11-20 |
13D/A
|
VBIVQ / VBI Vaccines Inc.
|
|
1,381,355 |
1,381,355 |
|
|
|
2023-11-17 |
13D/A
|
NAUT / Nautilus Biotechnology, Inc.
|
|
8,911,151 |
12,594,211 |
|
|
|
2023-11-14 |
13G
|
CRGX / CARGO Therapeutics, Inc.
|
|
|
3,246,168 |
|
|
|
2023-10-23 |
13D/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
3,074,542 |
3,074,542 |
|
|
|
2023-10-19 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
8,593,586 |
8,593,586 |
|
|
|
2023-10-18 |
13D/A
|
ATXS / Astria Therapeutics, Inc.
|
|
2,487,802 |
3,627,693 |
|
|
|
2023-10-18 |
13D/A
|
US04685N2027 / ATHENEX INC
|
|
0 |
0 |
|
|
|
2023-10-17 |
13D/A
|
CERE / Cerevel Therapeutics Holdings, Inc.
|
|
10,088,385 |
10,965,193 |
|
|
|
2023-09-29 |
13D/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
2,207,753 |
3,074,542 |
|
|
|
2023-09-13 |
13G
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
|
2,432,089 |
|
|
|
2023-09-08 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
0 |
3,627,775 |
|
|
|
2023-08-15 |
13D/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
2,207,753 |
2,207,753 |
|
|
|
2023-06-06 |
13D/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
2,029,455 |
2,207,753 |
|
|
|
2023-06-02 |
13D/A
|
LYRA / Lyra Therapeutics, Inc.
|
|
9,146,731 |
12,757,563 |
|
|
|
2023-05-30 |
13D/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
1,944,455 |
2,029,455 |
|
|
|
2023-05-25 |
13D/A
|
SLNO / Soleno Therapeutics, Inc.
|
|
1,864,455 |
1,944,455 |
|
|
|
2023-05-18 |
13D
|
SLNO / Soleno Therapeutics, Inc.
|
|
|
1,864,455 |
|
|
|
2023-05-16 |
13D/A
|
MGTX / MeiraGTx Holdings plc
|
|
6,973,737 |
11,406,563 |
|
|
|
2023-05-04 |
13D/A
|
CEMI / Chembio Diagnostics Inc.
|
|
4,919,334 |
0 |
|
|
|
2023-04-25 |
13D/A
|
CERE / Cerevel Therapeutics Holdings, Inc.
|
|
10,088,385 |
10,088,385 |
|
|
|
2023-04-24 |
13D/A
|
CEMI / Chembio Diagnostics Inc.
|
|
4,425,100 |
4,919,334 |
|
|
|
2023-04-21 |
13D
|
CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
10,088,385 |
|
|
|
2023-04-20 |
13G
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
4,462,666 |
|
|
|
2023-04-07 |
13D
|
CEMI / Chembio Diagnostics Inc.
|
|
|
4,425,100 |
|
|
|
2023-04-07 |
13D/A
|
VBIV / VBI Vaccines Inc.
|
|
8,634,668 |
43,509,553 |
|
|
|
2023-03-30 |
13D/A
|
LABP / Landos Biopharma, Inc.
|
|
14,869,915 |
14,869,915 |
|
|
|
2023-03-14 |
13G
|
BLPH / Bellerophon Therapeutics, Inc.
|
|
|
930,000 |
|
|
|
2023-03-10 |
13G
|
CBAY / CymaBay Therapeutics, Inc.
|
|
0 |
5,278,962 |
|
|
|
2023-03-07 |
13G
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
2,083,799 |
|
|
|
2023-02-14 |
13G/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
2,483,619 |
2,483,619 |
|
|
|
2023-02-14 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc
|
|
|
0 |
|
|
|
2023-02-14 |
13G/A
|
RACB / Research Alliance Corp II - Class A
|
|
1,000,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
3,610,412 |
5,038,983 |
|
|
|
2023-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
2,150,641 |
1,800,000 |
|
|
|
2023-02-14 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
3,283,783 |
2,191,425 |
|
|
|
2023-02-14 |
13G/A
|
INBX.V / Inhibrx, Inc.
|
|
1,968,744 |
3,313,783 |
|
|
|
2023-02-14 |
13G/A
|
RXDX / Prometheus Biosciences Inc
|
|
3,172,785 |
1,212,694 |
|
|
|
2023-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
11,933,387 |
11,900,255 |
|
|
|
2023-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
27,356,043 |
27,642,917 |
|
|
|
2023-02-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
2,927,565 |
1,798,955 |
|
|
|
2023-02-14 |
13G/A
|
BLU / Bellus Health Inc
|
|
7,645,234 |
8,891,027 |
|
|
|
2023-02-14 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
10,127,941 |
9,971,780 |
|
|
|
2023-02-14 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
6,480,000 |
587,400 |
|
|
|
2023-02-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
9,903,879 |
11,350,085 |
|
|
|
2023-02-14 |
13G/A
|
ACRV / Acrivon Therapeutics, Inc.
|
|
3,007,858 |
3,007,858 |
|
|
|
2023-02-14 |
13G/A
|
ISO / IsoPlexis Corp
|
|
4,875,530 |
4,095,498 |
|
|
|
2023-02-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
1,296,416 |
1,296,416 |
|
|
|
2023-02-14 |
13G/A
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
2,971,413 |
6,088,333 |
|
|
|
2023-02-14 |
13G
|
VERU / Veru Inc.
|
|
|
7,858,011 |
|
|
|
2023-02-14 |
13G/A
|
CHRS / Coherus Oncology, Inc.
|
|
5,407,798 |
0 |
|
|
|
2023-02-14 |
13G
|
CINC / CinCor Pharma Inc
|
|
|
2,576,325 |
|
|
|
2023-02-14 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
4,849,912 |
2,617,691 |
|
|
|
2023-02-14 |
13G/A
|
US00847L2097 / AGILE THERAPEUTICS INC
|
|
|
0 |
|
|
|
2023-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
2,360,139 |
1,757,160 |
|
|
|
2023-02-14 |
13G
|
ACLX / Arcellx, Inc.
|
|
|
2,598,305 |
|
|
|
2023-02-14 |
13G/A
|
NVNO / enVVeno Medical Corporation
|
|
954,248 |
937,515 |
|
|
|
2023-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
|
4,511,275 |
|
|
|
2023-02-14 |
13G
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
2,860,000 |
|
|
|
2023-02-14 |
13G/A
|
LPTX / Leap Therapeutics, Inc.
|
|
8,476,496 |
6,726,496 |
|
|
|
2023-02-03 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
3,501,265 |
3,501,265 |
|
|
|
2023-02-02 |
13D
|
ATNX / Athenex Inc
|
|
13,532,467 |
15,532,467 |
|
|
|
2023-01-13 |
13D/A
|
LABP / Landos Biopharma, Inc.
|
|
14,869,915 |
14,869,915 |
|
|
|
2022-12-21 |
13D/A
|
ATXS / Astria Therapeutics, Inc.
|
|
7,687,185 |
2,487,802 |
|
|
|
2022-12-06 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
13,462,552 |
3,501,265 |
|
|
|
2022-11-18 |
13G
|
ACRV / Acrivon Therapeutics, Inc.
|
|
|
3,007,858 |
|
|
|
2022-11-03 |
13G/A
|
QTNT / Quotient Ltd
|
|
16,200,818 |
0 |
|
|
|
2022-09-23 |
13G
|
RLMD / Relmada Therapeutics, Inc.
|
|
|
2,099,952 |
|
|
|
2022-09-02 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
13,412,552 |
13,462,552 |
|
|
|
2022-08-09 |
13D/A
|
LABP / Landos Biopharma, Inc.
|
|
17,960,839 |
14,869,915 |
|
|
|
2022-07-19 |
13G
|
INBX / Inhibrx Biosciences, Inc.
|
|
|
1,968,744 |
|
|
|
2022-07-01 |
13D/A
|
ATHA / Athira Pharma, Inc.
|
|
3,425,916 |
4,811,149 |
|
|
|
2022-06-21 |
13G
|
AMLX / Amylyx Pharmaceuticals, Inc.
|
|
|
2,971,413 |
|
|
|
2022-04-26 |
13D/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
5,333,532 |
5,333,532 |
|
|
|
2022-04-21 |
13D/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
3,659,381 |
5,333,532 |
|
|
|
2022-04-14 |
13D/A
|
LYRA / Lyra Therapeutics, Inc.
|
|
3,222,561 |
9,146,731 |
|
|
|
2022-03-02 |
13G
|
FOLD / Amicus Therapeutics, Inc.
|
|
26,559,443 |
27,356,043 |
|
|
|
2022-03-02 |
13D/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
26,559,443 |
27,356,043 |
|
|
|
2022-02-22 |
13D
|
FOLD / Amicus Therapeutics, Inc.
|
|
26,559,443 |
26,559,443 |
|
|
|
2022-02-15 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
11,933,387 |
11,933,387 |
|
|
|
2022-02-15 |
13G/A
|
COLL / Collegium Pharmaceutical, Inc.
|
|
2,058,068 |
0 |
|
|
|
2022-02-15 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
4,177,721 |
4,849,912 |
|
|
|
2022-02-15 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
4,300,999 |
3,679,845 |
|
|
|
2022-02-15 |
13G/A
|
BLSA / BCLS Acquisition Corp - Class A
|
|
1,000,000 |
1,000,000 |
|
|
|
2022-02-15 |
13G/A
|
LPTX / Leap Therapeutics, Inc.
|
|
8,476,496 |
8,476,496 |
|
|
|
2022-02-15 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
608,544 |
421,641 |
|
|
|
2022-02-15 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
4,987,887 |
2,425,604 |
|
|
|
2022-02-15 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
3,693,516 |
3,283,783 |
|
|
|
2022-02-15 |
13G/A
|
ONCR / Oncorus, Inc.
|
|
1,989,987 |
999,812 |
|
|
|
2022-02-15 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
4,482,713 |
6,480,000 |
|
|
|
2022-02-15 |
13G/A
|
PNT / POINT Biopharma Global Inc.
|
|
1,193,995 |
1,193,995 |
|
|
|
2022-02-15 |
13G/A
|
CHRS / Coherus Oncology, Inc.
|
|
4,671,836 |
5,407,798 |
|
|
|
2022-02-15 |
13G/A
|
OM / Outset Medical, Inc.
|
|
2,847,822 |
1,863,397 |
|
|
|
2022-02-15 |
13G/A
|
ANAB / AnaptysBio, Inc.
|
|
1,495,336 |
0 |
|
|
|
2022-02-15 |
13G/A
|
BBIO / BridgeBio Pharma, Inc.
|
|
6,706,268 |
7,128,755 |
|
|
|
2022-02-15 |
13G/A
|
QTNT / Quotient Ltd
|
|
16,200,818 |
16,200,818 |
|
|
|
2022-02-14 |
13G/A
|
CCCC / C4 Therapeutics, Inc.
|
|
3,158,566 |
2,208,913 |
|
|
|
2022-02-14 |
13G/A
|
FREQ / Frequency Therapeutics Inc
|
|
3,259,635 |
0 |
|
|
|
2022-02-14 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
1,577,481 |
2,927,565 |
|
|
|
2022-02-14 |
13G/A
|
SCYX / SCYNEXIS, Inc.
|
|
1,300,000 |
0 |
|
|
|
2022-02-14 |
13G/A
|
RXDX / Prometheus Biosciences Inc
|
|
|
3,172,785 |
|
|
|
2022-02-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
1,296,416 |
1,296,416 |
|
|
|
2022-02-14 |
13G/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
3,396,867 |
1,959,125 |
|
|
|
2022-02-14 |
13G/A
|
PRVB / Provention Bio Inc
|
|
3,633,023 |
948,481 |
|
|
|
2022-02-14 |
13G/A
|
RACB / Research Alliance Corp II - Class A
|
|
1,000,000 |
1,000,000 |
|
|
|
2022-02-14 |
13G/A
|
FBRX / Forte Biosciences, Inc.
|
|
700,000 |
0 |
|
|
|
2022-02-14 |
13G/A
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
2,537,019 |
2,483,619 |
|
|
|
2022-02-14 |
13G/A
|
ISO / IsoPlexis Corp
|
|
4,906,872 |
4,875,530 |
|
|
|
2022-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,493,607 |
1,845,555 |
|
|
|
2022-02-14 |
13G/A
|
BLU / Bellus Health Inc
|
|
4,741,354 |
7,645,234 |
|
|
|
2022-02-14 |
13G/A
|
NVNO / enVVeno Medical Corporation
|
|
954,248 |
954,248 |
|
|
|
2022-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
2,360,139 |
2,360,139 |
|
|
|
2022-02-14 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
22,214,683 |
10,055,521 |
|
|
|
2022-02-14 |
13G/A
|
AGRX / Agile Therapeutics, Inc.
|
|
15,919,925 |
21,294,485 |
|
|
|
2022-02-14 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
3,410,412 |
3,610,412 |
|
|
|
2022-02-14 |
13G/A
|
ATNX / Athenex Inc
|
|
13,532,467 |
13,532,467 |
|
|
|
2022-02-14 |
13G/A
|
GBT / Global Blood Therapeutics Inc.
|
|
5,674,711 |
3,449,915 |
|
|
|
2022-02-14 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
9,166,304 |
10,127,941 |
|
|
|
2022-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
2,150,641 |
2,150,641 |
|
|
|
2022-02-14 |
13G/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
4,422,123 |
0 |
|
|
|
2022-02-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
8,703,879 |
9,903,879 |
|
|
|
2022-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
25,112,048 |
26,559,443 |
|
|
|
2021-12-06 |
13G
|
BLU / Bellus Health Inc
|
|
|
4,741,354 |
|
|
|
2021-11-15 |
13D
|
/ LIANBIO
|
|
|
56,319,960 |
|
|
|
2021-10-27 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
16,584,802 |
11,933,387 |
|
|
|
2021-10-22 |
13G
|
ISO / IsoPlexis Corp
|
|
|
4,906,872 |
|
|
|
2021-09-17 |
13G
|
NVNO / enVVeno Medical Corporation
|
|
|
954,248 |
|
|
|
2021-08-25 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
27,095,819 |
4,987,887 |
|
|
|
2021-06-25 |
13D/A
|
ATXS / Astria Therapeutics, Inc.
|
|
2,476,924 |
7,687,185 |
|
|
|
2021-06-21 |
13D
|
/ Nautilus Biotechnology Inc
|
|
|
8,911,151 |
|
|
|
2021-05-03 |
13G
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
|
2,537,019 |
|
|
|
2021-04-19 |
13G/A
|
PRVB / Provention Bio Inc
|
|
4,224,389 |
3,633,023 |
|
|
|
2021-04-06 |
13D/A
|
LABP / Landos Biopharma, Inc.
|
|
17,960,839 |
17,960,839 |
|
|
|
2021-03-26 |
13G
|
RACB / Research Alliance Corp II - Class A
|
|
|
1,000,000 |
|
|
|
2021-03-23 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
10,803,857 |
13,412,552 |
|
|
|
2021-03-22 |
13G
|
FBRX / Forte Biosciences, Inc.
|
|
|
700,000 |
|
|
|
2021-02-18 |
13D
|
LABP / Landos Biopharma, Inc.
|
|
|
17,960,839 |
|
|
|
2021-02-17 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
0 |
3,410,412 |
|
|
|
2021-02-16 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
25,132,364 |
25,112,048 |
|
|
|
2021-02-16 |
13G/A
|
COLL / Collegium Pharmaceutical, Inc.
|
|
1,721,722 |
2,058,068 |
|
|
|
2021-02-16 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
2,150,641 |
2,150,641 |
|
|
|
2021-02-16 |
13G/A
|
LPTX / Leap Therapeutics, Inc.
|
|
6,726,496 |
8,476,496 |
|
|
|
2021-02-16 |
13G/A
|
QTNT / Quotient Ltd
|
|
13,289,054 |
16,200,818 |
|
|
|
2021-02-16 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
18,436,906 |
22,214,683 |
|
|
|
2021-02-16 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
3,253,923 |
2,577,043 |
|
|
|
2021-02-16 |
13G/A
|
AGRX / Agile Therapeutics, Inc.
|
|
11,919,925 |
15,919,925 |
|
|
|
2021-02-16 |
13G
|
G78516203 / SC Health Corp
|
|
|
1,000,000 |
|
|
|
2021-02-16 |
13G/A
|
KDMN / Kadmon Holdings Inc
|
|
15,165,747 |
16,240,747 |
|
|
|
2021-02-16 |
13G
|
CCCC / C4 Therapeutics, Inc.
|
|
|
3,158,566 |
|
|
|
2021-02-16 |
13G
|
OM / Outset Medical, Inc.
|
|
|
2,847,822 |
|
|
|
2021-02-16 |
13G
|
ONCR / Oncorus, Inc.
|
|
|
1,989,987 |
|
|
|
2021-02-16 |
13G
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
1,296,416 |
|
|
|
2021-02-16 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
3,410,412 |
0 |
|
|
|
2021-02-16 |
13G
|
/ Therapeutics Acquisition Corp. Class A
|
|
|
1,500,000 |
|
|
|
2021-02-16 |
13G
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
3,396,867 |
|
|
|
2021-02-16 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
6,600,660 |
0 |
|
|
|
2021-02-16 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
3,164,133 |
601,818 |
|
|
|
2021-02-16 |
13G/A
|
AQST / Aquestive Therapeutics, Inc.
|
|
2,250,000 |
1,385,720 |
|
|
|
2021-02-16 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
1,141,484 |
0 |
|
|
|
2021-02-16 |
13G/A
|
VYNE / VYNE Therapeutics Inc.
|
|
22,876,410 |
27,095,819 |
|
|
|
2021-02-16 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
2,403,026 |
4,300,999 |
|
|
|
2021-02-16 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
16,084,802 |
16,584,802 |
|
|
|
2021-02-16 |
13G/A
|
UROV / Urovant Sciences Ltd
|
|
2,406,931 |
3,116,831 |
|
|
|
2021-02-16 |
13G/A
|
TARA / Protara Therapeutics, Inc.
|
|
608,544 |
608,544 |
|
|
|
2021-02-16 |
13G/A
|
KOD / Kodiak Sciences Inc.
|
|
3,663,557 |
751,533 |
|
|
|
2021-02-16 |
13G/A
|
ATNX / Athenex Inc
|
|
11,532,467 |
13,532,467 |
|
|
|
2021-02-16 |
13G/A
|
GBT / Global Blood Therapeutics Inc.
|
|
5,865,726 |
5,674,711 |
|
|
|
2021-02-16 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
3,297,522 |
4,177,721 |
|
|
|
2021-02-16 |
13G/A
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
1,000,000 |
|
|
|
2021-02-16 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
1,704,330 |
2,360,139 |
|
|
|
2021-02-16 |
13G/A
|
CHRS / Coherus Oncology, Inc.
|
|
3,586,485 |
4,671,836 |
|
|
|
2021-02-16 |
13G/A
|
BBIO / BridgeBio Pharma, Inc.
|
|
6,706,268 |
6,706,268 |
|
|
|
2021-02-16 |
13G/A
|
FREQ / Frequency Therapeutics Inc
|
|
3,034,296 |
3,259,635 |
|
|
|
2021-02-16 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
4,482,713 |
4,482,713 |
|
|
|
2021-02-16 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
9,411,396 |
9,166,304 |
|
|
|
2021-02-16 |
13G/A
|
RAPT / RAPT Therapeutics, Inc.
|
|
1,327,481 |
1,577,481 |
|
|
|
2021-02-16 |
13G/A
|
PRVB / Provention Bio Inc
|
|
2,921,574 |
4,224,389 |
|
|
|
2021-02-16 |
13G/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
2,771,090 |
4,422,123 |
|
|
|
2021-02-16 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
2,890,608 |
3,493,607 |
|
|
|
2021-02-16 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
3,203,406 |
3,693,516 |
|
|
|
2021-02-16 |
13G/A
|
ZGNX / Zogenix Inc
|
|
3,709,152 |
0 |
|
|
|
2021-02-16 |
13G/A
|
VAPO / Vapotherm, Inc.
|
|
1,804,075 |
0 |
|
|
|
2021-02-16 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
6,285,458 |
8,703,879 |
|
|
|
2021-02-08 |
13D
|
ATXS / Astria Therapeutics, Inc.
|
|
|
2,476,924 |
|
|
|
2021-02-08 |
13D
|
ATHA / Athira Pharma, Inc.
|
|
|
3,425,916 |
|
|
|
2021-02-08 |
13G
|
ANAB / AnaptysBio, Inc.
|
|
|
1,495,336 |
|
|
|
2021-01-27 |
13G/A
|
MOTS / Motus GI Holdings, Inc.
|
|
4,210,542 |
2,660,542 |
|
|
|
2021-01-27 |
13G
|
SCYX / SCYNEXIS, Inc.
|
|
|
1,300,000 |
|
|
|
2020-12-17 |
13D/A
|
SLDB / Solid Biosciences Inc.
|
|
6,749,803 |
10,803,857 |
|
|
|
2020-12-14 |
13G
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
1,327,481 |
|
|
|
2020-11-24 |
13D/A
|
MGTX / MeiraGTx Holdings plc
|
|
6,448,737 |
6,973,737 |
|
|
|
2020-10-28 |
13G
|
ISEE / IVERIC bio Inc
|
|
|
4,482,713 |
|
|
|
2020-10-28 |
13G
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
1,000,000 |
|
|
|
2020-10-07 |
13G
|
CHRS / Coherus Oncology, Inc.
|
|
|
3,586,485 |
|
|
|
2020-10-01 |
13G
|
TARA / Protara Therapeutics, Inc.
|
|
|
608,544 |
|
|
|
2020-07-13 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
3,085,458 |
6,285,458 |
|
|
|
2020-06-11 |
13G
|
VYNE / VYNE Therapeutics Inc.
|
|
|
22,876,410 |
|
|
|
2020-06-01 |
13D
|
LYRA / Lyra Therapeutics, Inc.
|
|
|
3,222,561 |
|
|
|
2020-05-22 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
13,436,906 |
18,436,906 |
|
|
|
2020-04-28 |
13D/A
|
|
|
|
57,111,289 |
|
|
|
2020-04-22 |
13G
|
COLL / Collegium Pharmaceutical, Inc.
|
|
|
1,721,722 |
|
|
|
2020-04-20 |
13G
|
LPTX / Leap Therapeutics, Inc.
|
|
|
6,726,496 |
|
|
|
2020-04-20 |
13D/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
2,587,953 |
3,659,381 |
|
|
|
2020-02-18 |
13G/A
|
PRVB / Provention Bio Inc
|
|
0 |
2,921,574 |
|
|
|
2020-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
20,724,424 |
25,132,364 |
|
|
|
2020-02-14 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
2,164,133 |
3,164,133 |
|
|
|
2020-02-14 |
13G/A
|
CBAY / CymaBay Therapeutics, Inc.
|
|
4,242,821 |
0 |
|
|
|
2020-02-14 |
13G/A
|
AGRX / Agile Therapeutics, Inc.
|
|
11,919,925 |
11,919,925 |
|
|
|
2020-02-14 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
6,600,660 |
6,600,660 |
|
|
|
2020-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
845,000 |
1,704,330 |
|
|
|
2020-02-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
3,085,458 |
3,085,458 |
|
|
|
2020-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
11,521,102 |
16,084,802 |
|
|
|
2020-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
1,365,579 |
0 |
|
|
|
2020-02-14 |
13G/A
|
AQST / Aquestive Therapeutics, Inc.
|
|
2,113,400 |
2,250,000 |
|
|
|
2020-02-14 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
12,241,305 |
9,411,396 |
|
|
|
2020-02-14 |
13G/A
|
TVTX / Travere Therapeutics, Inc.
|
|
3,399,538 |
2,890,608 |
|
|
|
2020-02-14 |
13G/A
|
KOD / Kodiak Sciences Inc.
|
|
3,135,199 |
3,663,557 |
|
|
|
2020-02-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
2,991,715 |
3,253,923 |
|
|
|
2020-02-14 |
13G/A
|
KDMN / Kadmon Holdings Inc
|
|
13,165,746 |
15,165,747 |
|
|
|
2020-02-14 |
13G/A
|
QTNT / Quotient Ltd
|
|
10,789,054 |
13,289,054 |
|
|
|
2020-02-14 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
11,203,881 |
11,203,881 |
|
|
|
2020-02-14 |
13G/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
1,636,331 |
2,771,090 |
|
|
|
2020-02-14 |
13G/A
|
MOTS / Motus GI Holdings, Inc.
|
|
3,210,542 |
4,210,542 |
|
|
|
2020-02-14 |
13G/A
|
ESTA / Establishment Labs Holdings Inc.
|
|
1,260,528 |
1,050,528 |
|
|
|
2020-02-14 |
13G/A
|
FREQ / Frequency Therapeutics Inc
|
|
3,034,296 |
3,034,296 |
|
|
|
2020-02-14 |
13G/A
|
SLDB / Solid Biosciences Inc.
|
|
3,927,222 |
6,749,803 |
|
|
|
2020-02-14 |
13G/A
|
BBIO / BridgeBio Pharma, Inc.
|
|
6,586,268 |
6,706,268 |
|
|
|
2020-02-14 |
13G/A
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
3,297,522 |
|
|
|
2020-02-14 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
4,608,554 |
3,612,554 |
|
|
|
2020-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
2,253,376 |
0 |
|
|
|
2020-02-14 |
13G/A
|
VRAY / ViewRay Inc.
|
|
4,990,243 |
2,451,748 |
|
|
|
2020-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
3,790,216 |
3,709,152 |
|
|
|
2020-02-14 |
13G/A
|
ZYME / Zymeworks Inc.
|
|
2,349,147 |
2,403,026 |
|
|
|
2020-02-14 |
13G/A
|
ATNX / Athenex Inc
|
|
9,621,022 |
11,532,467 |
|
|
|
2020-02-14 |
13G/A
|
PRVB / Provention Bio Inc
|
|
2,391,574 |
0 |
|
|
|
2020-02-14 |
13G/A
|
MRKR / Marker Therapeutics, Inc.
|
|
3,500,000 |
0 |
|
|
|
2020-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
1,873,779 |
2,150,641 |
|
|
|
2020-02-14 |
13G/A
|
VAPO / Vapotherm, Inc.
|
|
1,286,623 |
1,804,075 |
|
|
|
2020-02-14 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
|
13,436,906 |
|
|
|
2020-02-14 |
13G/A
|
UROV / Urovant Sciences Ltd
|
|
1,598,277 |
2,406,931 |
|
|
|
2020-02-14 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
3,410,412 |
3,410,412 |
|
|
|
2020-02-14 |
13G/A
|
GBT / Global Blood Therapeutics Inc.
|
|
5,425,726 |
5,865,726 |
|
|
|
2020-02-14 |
13G/A
|
ONCT / Oncternal Therapeutics, Inc.
|
|
|
0 |
|
|
|
2020-02-14 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
1,341,484 |
1,141,484 |
|
|
|
2020-02-14 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
1,829,206 |
3,203,406 |
|
|
|
2019-12-23 |
13G
|
PRVB / Provention Bio Inc
|
|
|
2,391,574 |
|
|
|
2019-11-18 |
13G/A
|
DOVA / Dova Pharmaceuticals, Inc.
|
|
0 |
0 |
|
|
|
2019-11-18 |
13G/A
|
AGRX / Agile Therapeutics, Inc.
|
|
6,911,401 |
11,919,925 |
|
|
|
2019-11-15 |
13G/A
|
DOVA / Dova Pharmaceuticals, Inc.
|
|
3,125,851 |
0 |
|
|
|
2019-10-30 |
13G/A
|
AGRX / Agile Therapeutics, Inc.
|
|
8,426,750 |
6,911,401 |
|
|
|
2019-10-11 |
13G
|
FREQ / Frequency Therapeutics Inc
|
|
|
3,034,296 |
|
|
|
2019-09-26 |
13D/A
|
LVVNF / Levon Resources Ltd.
|
|
28,020,380 |
48,020,380 |
|
|
|
2019-09-26 |
13G
|
SWTX / SpringWorks Therapeutics, Inc.
|
|
|
3,217,522 |
|
|
|
2019-09-25 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
4,400,440 |
6,600,660 |
|
|
|
2019-08-20 |
13D/A
|
MGTX / MeiraGTx Holdings plc
|
|
6,023,206 |
6,448,737 |
|
|
|
2019-08-06 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
4,661,824 |
11,203,881 |
|
|
|
2019-07-11 |
13G
|
BBIO / BridgeBio Pharma, Inc.
|
|
|
6,586,268 |
|
|
|
2019-07-02 |
13G
|
ZYME / Zymeworks Inc.
|
|
|
2,349,147 |
|
|
|
2019-06-24 |
13G
|
UROV / Urovant Sciences Ltd
|
|
|
1,598,277 |
|
|
|
2019-06-20 |
13D/A
|
LVVNF / Levon Resources Ltd.
|
|
25,700,263 |
28,020,380 |
|
|
|
2019-05-29 |
13G
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
1,341,484 |
|
|
|
2019-05-28 |
13G
|
ESTA / Establishment Labs Holdings Inc.
|
|
614,242 |
1,260,528 |
|
|
|
2019-05-23 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
6,521,102 |
11,521,102 |
|
|
|
2019-05-16 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
1,829,206 |
|
|
|
2019-05-09 |
13G
|
VRAY / ViewRay Inc.
|
|
|
4,990,243 |
|
|
|
2019-05-08 |
13G/A
|
ATNX / Athenex Inc
|
|
5,521,022 |
9,621,022 |
|
|
|
2019-03-11 |
13G
|
CBAY / CymaBay Therapeutics, Inc.
|
|
2,462,821 |
4,242,821 |
|
|
|
2019-03-06 |
13G
|
AGRX / Agile Therapeutics, Inc.
|
|
0 |
8,426,750 |
|
|
|
2019-03-05 |
13D/A
|
MGTX / MeiraGTx Holdings plc
|
|
4,703,398 |
6,023,206 |
|
|
|
2019-02-20 |
13G/A
|
ESTA / Establishment Labs Holdings Inc.
|
|
1,344,242 |
614,242 |
|
|
|
2019-02-14 |
13G/A
|
ADYX / Adynxx, Inc.
|
|
|
0 |
|
|
|
2019-02-14 |
13G
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
3,091,903 |
12,241,305 |
|
|
|
2019-02-14 |
13G
|
AQST / Aquestive Therapeutics, Inc.
|
|
|
2,113,400 |
|
|
|
2019-02-14 |
13G
|
TVTX / Travere Therapeutics, Inc.
|
|
|
3,399,538 |
|
|
|
2019-02-14 |
13G
|
VAPO / Vapotherm, Inc.
|
|
|
1,286,623 |
|
|
|
2019-02-14 |
13G
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
12,241,305 |
|
|
|
2019-02-14 |
13G/A
|
MEIP / MEI Pharma, Inc.
|
|
6,600,660 |
4,400,440 |
|
|
|
2019-02-14 |
13G/A
|
DOVA / Dova Pharmaceuticals, Inc.
|
|
2,931,151 |
3,125,851 |
|
|
|
2019-02-14 |
13G/A
|
OCGN / Ocugen, Inc.
|
|
2,203,277 |
0 |
|
|
|
2019-02-14 |
13G/A
|
OMED / OptMed Inc
|
|
2,620,897 |
1,719,111 |
|
|
|
2019-02-14 |
13G/A
|
QTNT / Quotient Ltd
|
|
8,339,054 |
10,789,054 |
|
|
|
2019-02-14 |
13G/A
|
MOTS / Motus GI Holdings, Inc.
|
|
|
3,210,542 |
|
|
|
2019-02-14 |
13G/A
|
KOD / Kodiak Sciences Inc.
|
|
3,172,955 |
3,135,199 |
|
|
|
2019-02-14 |
13G/A
|
ATNX / Athenex Inc
|
|
3,357,128 |
5,521,022 |
|
|
|
2019-02-14 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
8,374,015 |
8,891,452 |
|
|
|
2019-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
1,291,355 |
1,365,579 |
|
|
|
2019-02-14 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
1,320,000 |
1,704,330 |
|
|
|
2019-02-14 |
13G/A
|
AGRX / Agile Therapeutics, Inc.
|
|
3,530,000 |
0 |
|
|
|
2019-02-14 |
13G/A
|
SRRA / Sierra Oncology Inc
|
|
5,000,000 |
2,666,190 |
|
|
|
2019-02-14 |
13G/A
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
3,307,424 |
4,661,824 |
|
|
|
2019-02-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
2,490,381 |
2,991,715 |
|
|
|
2019-02-14 |
13G/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
1,426,772 |
1,636,331 |
|
|
|
2019-02-14 |
13G/A
|
MTEM / Molecular Templates, Inc.
|
|
1,975,133 |
2,164,133 |
|
|
|
2019-02-14 |
13G
|
MRKR / Marker Therapeutics, Inc.
|
|
|
3,500,000 |
|
|
|
2019-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
2,391,841 |
14,860 |
|
|
|
2019-02-14 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
5,151,589 |
4,608,554 |
|
|
|
2019-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
17,888,597 |
20,724,424 |
|
|
|
2019-02-14 |
13G/A
|
CBAY / CymaBay Therapeutics, Inc.
|
|
2,685,882 |
2,462,821 |
|
|
|
2019-02-14 |
13G/A
|
GBT / Global Blood Therapeutics Inc.
|
|
4,889,066 |
5,425,726 |
|
|
|
2019-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
3,970,357 |
3,790,216 |
|
|
|
2019-02-14 |
13G/A
|
ALQA / Alliqua, Inc.
|
|
429,108 |
0 |
|
|
|
2019-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
1,215,479 |
1,873,779 |
|
|
|
2019-02-14 |
13G/A
|
KDMN / Kadmon Holdings Inc
|
|
13,165,746 |
13,165,746 |
|
|
|
2019-02-14 |
13G
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
1,344,242 |
|
|
|
2019-02-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
3,085,458 |
3,085,458 |
|
|
|
2019-02-14 |
13G
|
SLDB / Solid Biosciences Inc.
|
|
|
3,927,222 |
|
|
|
2019-02-14 |
13G/A
|
GTXO / GTX Corp
|
|
1,501,501 |
1,443,333 |
|
|
|
2019-02-14 |
13G/A
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
3,410,412 |
3,410,412 |
|
|
|
2019-02-14 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
3,821,102 |
6,521,102 |
|
|
|
2019-01-11 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
3,388,611 |
2,253,376 |
|
|
|
2018-12-17 |
13D/A
|
LVVNF / Levon Resources Ltd.
|
|
|
25,700,263 |
|
|
|
2018-12-10 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
1,291,355 |
|
|
|
2018-11-23 |
13G
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
1,215,479 |
|
|
|
2018-11-16 |
13G
|
ATNX / Athenex Inc
|
|
|
3,357,128 |
|
|
|
2018-10-19 |
13G
|
KOD / Kodiak Sciences Inc.
|
|
|
3,172,955 |
|
|
|
2018-10-16 |
13G/A
|
CORI / Corium International, Inc.
|
|
5,847,133 |
0 |
|
|
|
2018-09-27 |
13G
|
MTEM / Molecular Templates, Inc.
|
|
|
1,975,133 |
|
|
|
2018-09-24 |
13G
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
3,307,424 |
|
|
|
2018-09-05 |
13G
|
MEIP / MEI Pharma, Inc.
|
|
|
6,600,660 |
|
|
|
2018-08-28 |
13D/A
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
2,280,305 |
2,587,953 |
|
|
|
2018-08-02 |
13G
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
|
3,410,412 |
|
|
|
2018-07-30 |
13D
|
CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
2,280,305 |
|
|
|
2018-06-22 |
13D
|
MGTX / MeiraGTx Holdings plc
|
|
|
4,703,398 |
|
|
|
2018-06-22 |
13G/A
|
KDMN / Kadmon Holdings Inc
|
|
6,356,221 |
13,165,746 |
|
|
|
2018-06-07 |
13G/A
|
DOVA / Dova Pharmaceuticals, Inc.
|
|
1,809,015 |
2,931,151 |
|
|
|
2018-05-29 |
13G
|
GTXO / GTX Corp
|
|
|
1,501,501 |
|
|
|
2018-03-28 |
13G/A
|
AGRX / Agile Therapeutics, Inc.
|
|
3,380,000 |
3,530,000 |
|
|
|
2018-02-26 |
13G
|
MOTS / Motus GI Holdings, Inc.
|
|
|
2,866,541 |
|
|
|
2018-02-14 |
13G/A
|
ARAV / Aravive, Inc.
|
|
|
1,488,160 |
|
|
|
2018-02-14 |
13G/A
|
ADYX / Adynxx, Inc.
|
|
|
429,108 |
|
|
|
2018-02-14 |
13G/A
|
ABEO / Abeona Therapeutics Inc.
|
|
2,101,809 |
1,319,298 |
|
|
|
2018-02-14 |
13G/A
|
PSDV / pSivida Corp.
|
|
2,279,706 |
0 |
|
|
|
2018-02-14 |
13G/A
|
CORI / Corium International, Inc.
|
|
3,847,133 |
5,847,133 |
|
|
|
2018-02-14 |
13G/A
|
QURE / uniQure N.V.
|
|
1,265,963 |
1,047,950 |
|
|
|
2018-02-14 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
3,567,553 |
3,091,903 |
|
|
|
2018-02-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
1,940,458 |
3,085,458 |
|
|
|
2018-02-14 |
13G/A
|
MGCD / MGC Diagnostics Corp.
|
|
329,733 |
0 |
|
|
|
2018-02-14 |
13G/A
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
842,128 |
0 |
|
|
|
2018-02-14 |
13G/A
|
ADMP / Adamis Pharmaceuticals Corp
|
|
1,500,000 |
0 |
|
|
|
2018-02-14 |
13G/A
|
OCRX / Ocera Therapeutics, Inc.
|
|
2,150,000 |
0 |
|
|
|
2018-02-14 |
13G/A
|
ACRS / Aclaris Therapeutics, Inc.
|
|
1,260,847 |
0 |
|
|
|
2018-02-14 |
13G/A
|
ARAV / Aravive, Inc.
|
|
2,099,563 |
1,488,160 |
|
|
|
2018-02-14 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
8,050,315 |
8,374,015 |
|
|
|
2018-02-14 |
13G/A
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
1,297,350 |
1,426,772 |
|
|
|
2018-02-14 |
13G/A
|
SRRA / Sierra Oncology Inc
|
|
3,655,186 |
5,000,000 |
|
|
|
2018-02-14 |
13G/A
|
ZGNX / Zogenix Inc
|
|
3,448,302 |
3,970,357 |
|
|
|
2018-02-14 |
13G/A
|
KDMN / Kadmon Holdings Inc
|
|
5,185,847 |
6,356,221 |
|
|
|
2018-02-14 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
4,657,589 |
5,151,589 |
|
|
|
2018-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
17,296,672 |
17,888,597 |
|
|
|
2018-02-14 |
13G/A
|
ALQA / Alliqua, Inc.
|
|
1,921,951 |
429,108 |
|
|
|
2018-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
2,391,841 |
|
|
|
2018-02-14 |
13G/A
|
OMED / OptMed Inc
|
|
2,470,897 |
2,620,897 |
|
|
|
2018-02-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
2,165,381 |
2,490,381 |
|
|
|
2018-02-14 |
13G/A
|
DOVA / Dova Pharmaceuticals, Inc.
|
|
|
1,809,015 |
|
|
|
2018-02-08 |
13D
|
SLDB / Solid Biosciences Inc.
|
|
|
3,927,222 |
|
|
|
2018-01-26 |
13G
|
OCGN / Ocugen, Inc.
|
|
|
2,203,277 |
|
|
|
2018-01-09 |
13G
|
AGRX / Agile Therapeutics, Inc.
|
|
|
3,380,000 |
|
|
|
2017-12-20 |
13G/A
|
GBT / Global Blood Therapeutics Inc.
|
|
3,128,978 |
4,889,066 |
|
|
|
2017-12-18 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
2,165,381 |
|
|
|
2017-12-18 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,319,274 |
3,388,611 |
|
|
|
2017-12-18 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
6,519,634 |
8,050,315 |
|
|
|
2017-12-06 |
13G
|
OMED / OptMed Inc
|
|
|
2,470,897 |
|
|
|
2017-12-04 |
13G/A
|
ALBO / Albireo Pharma Inc
|
|
|
1,320,000 |
|
|
|
2017-11-27 |
13G
|
SRRA / Sierra Oncology Inc
|
|
|
3,655,186 |
|
|
|
2017-11-15 |
13G/A
|
ADMA / ADMA Biologics, Inc.
|
|
721,102 |
3,821,102 |
|
|
|
2017-11-14 |
13G
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
2,685,882 |
|
|
|
2017-11-09 |
13G
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
2,241,841 |
|
|
|
2017-11-09 |
13G
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
2,241,841 |
|
|
|
2017-11-01 |
13G/A
|
QTNT / Quotient Ltd
|
|
8,349,054 |
8,339,054 |
|
|
|
2017-10-30 |
13D/A
|
LVVNF / Levon Resources Ltd.
|
|
|
11,414,549 |
|
|
|
2017-10-30 |
13G
|
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
1,297,350 |
|
|
|
2017-10-30 |
13D/A
|
SVACF / SciVac Therapeutics Inc.
|
|
|
11,414,549 |
|
|
|
2017-10-26 |
13G/A
|
QTNT / Quotient Ltd
|
|
2,854,486 |
8,349,054 |
|
|
|
2017-09-26 |
13G/A
|
ARAV / Aravive, Inc.
|
|
|
2,099,563 |
|
|
|
2017-09-26 |
13G/A
|
ARAV / Aravive, Inc.
|
|
4,153,685 |
2,099,563 |
|
|
|
2017-09-08 |
13G
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
4,657,589 |
|
|
|
2017-08-23 |
13G/A
|
ACRX / Talphera, Inc.
|
|
5,408,728 |
1,244,608 |
|
|
|
2017-08-01 |
13G
|
DOVA / Dova Pharmaceuticals, Inc.
|
|
|
1,704,015 |
|
|
|
2017-06-05 |
13G
|
ALBO / Albireo Pharma Inc
|
|
|
845,000 |
|
|
|
2017-05-23 |
13G/A
|
CORI / Corium International, Inc.
|
|
1,716,667 |
3,847,133 |
|
|
|
2017-05-09 |
13G/A
|
ZGNX / Zogenix Inc
|
|
1,285,302 |
3,448,302 |
|
|
|
2017-04-24 |
13G/A
|
ADMP / Adamis Pharmaceuticals Corp
|
|
1,500,000 |
1,350,000 |
|
|
|
2017-04-24 |
13G
|
ADMP / Adamis Pharmaceuticals Corp
|
|
|
1,500,000 |
|
|
|
2017-04-17 |
13G
|
OCRX / Ocera Therapeutics, Inc.
|
|
|
2,150,000 |
|
|
|
2017-03-17 |
13G
|
KDMN / Kadmon Holdings Inc
|
|
|
5,185,847 |
|
|
|
2017-03-09 |
13D/A
|
VBIV / VBI Vaccines Inc.
|
|
8,602,257 |
8,634,668 |
|
|
|
2017-02-22 |
13G
|
ZGNX / Zogenix Inc
|
|
|
1,285,302 |
|
|
|
2017-02-22 |
13G/A
|
ZGNX / Zogenix Inc
|
|
1,285,302 |
1,355,302 |
|
|
|
2017-02-15 |
13G
|
CORI / Corium International, Inc.
|
|
|
1,716,667 |
|
|
|
2017-02-14 |
13G/A
|
ALQA / Alliqua, Inc.
|
|
1,921,951 |
1,921,951 |
|
|
|
2017-02-14 |
13G/A
|
ARAV / Aravive, Inc.
|
|
4,028,685 |
4,153,685 |
|
|
|
2017-02-14 |
13G/A
|
ARNI / Arno Therapeutics, Inc.
|
|
2,034,721 |
4,177,577 |
|
|
|
2017-02-14 |
13G
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
1,260,847 |
|
|
|
2017-02-14 |
13G
|
ZYNE / Zynerba Pharmaceuticals Inc
|
|
|
842,128 |
|
|
|
2017-02-14 |
13G/A
|
ABEO / Abeona Therapeutics Inc.
|
|
1,762,881 |
2,101,809 |
|
|
|
2017-02-14 |
13G/A
|
451731103 / Ignyta, Inc.
|
|
1,812,060 |
6,584 |
|
|
|
2017-02-14 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
15,239,444 |
17,296,672 |
|
|
|
2017-02-14 |
13G/A
|
ACRX / Talphera, Inc.
|
|
5,995,760 |
5,408,728 |
|
|
|
2017-02-14 |
13G
|
QTNT / Quotient Ltd
|
|
|
2,854,486 |
|
|
|
2017-02-14 |
13G
|
PSDV / pSivida Corp.
|
|
|
2,279,706 |
|
|
|
2017-02-14 |
13G
|
QURE / uniQure N.V.
|
|
|
1,265,963 |
|
|
|
2017-02-14 |
13G
|
ADMA / ADMA Biologics, Inc.
|
|
|
721,102 |
|
|
|
2017-02-14 |
13G/A
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
1,240,458 |
1,940,458 |
|
|
|
2017-02-14 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
6,700,444 |
6,519,634 |
|
|
|
2017-02-14 |
13G
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
1,319,274 |
|
|
|
2017-02-14 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
3,000,161 |
3,567,553 |
|
|
|
2017-02-14 |
13G/A
|
MGCD / MGC Diagnostics Corp.
|
|
336,287 |
329,733 |
|
|
|
2017-02-14 |
13G
|
GBT / Global Blood Therapeutics Inc.
|
|
|
3,128,978 |
|
|
|
2016-12-12 |
13D
|
VBIV / VBI Vaccines Inc.
|
|
3,260,356 |
8,602,257 |
|
|
|
2016-10-05 |
13G/A
|
ARAV / Aravive, Inc.
|
|
2,299,454 |
4,028,685 |
|
|
|
2016-02-16 |
13G/A
|
ABEO / Abeona Therapeutics Inc.
|
|
|
1,762,881 |
|
|
|
2016-02-16 |
13G/A
|
ALQA / Alliqua, Inc.
|
|
1,921,951 |
1,921,951 |
|
|
|
2016-02-16 |
13G/A
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
3,000,161 |
|
|
|
2016-02-16 |
13G/A
|
ACRX / Talphera, Inc.
|
|
|
5,995,760 |
|
|
|
2016-02-16 |
13G
|
ARAV / Aravive, Inc.
|
|
|
2,299,454 |
|
|
|
2016-02-16 |
13G
|
451731103 / Ignyta, Inc.
|
|
|
1,812,060 |
|
|
|
2016-02-16 |
13G
|
VBIV / VBI Vaccines Inc.
|
|
|
3,260,356 |
|
|
|
2016-02-16 |
13G/A
|
MGCD / MGC Diagnostics Corp.
|
|
|
336,287 |
|
|
|
2016-02-16 |
13G/A
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
2,240,928 |
|
|
|
2016-02-16 |
13G/A
|
GNVC / GenVec, Inc.
|
|
|
615,844 |
|
|
|
2016-02-16 |
13G/A
|
NEPT / Neptune Wellness Solutions Inc.
|
|
|
6,700,444 |
|
|
|
2016-02-16 |
13G
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
1,240,458 |
|
|
|
2016-02-16 |
13G/A
|
XNCR / Xencor, Inc.
|
|
|
1,854,784 |
|
|
|
2016-02-16 |
13G/A
|
ARNI / Arno Therapeutics, Inc.
|
|
|
2,034,721 |
|
|
|
2016-02-16 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
15,239,444 |
|
|
|
2015-05-08 |
13G/A
|
ALQA / Alliqua, Inc.
|
|
|
1,921,951 |
|
|
|
2015-02-17 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
3,565,267 |
|
|
|
2015-02-17 |
13G/A
|
ACRX / Talphera, Inc.
|
|
|
6,574,060 |
|
|
|
2015-02-17 |
13G/A
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
14,439,444 |
|
|
|
2015-02-17 |
13G
|
ARNI / Arno Therapeutics, Inc.
|
|
|
2,034,721 |
|
|
|
2015-02-17 |
13G
|
ABEO / Abeona Therapeutics Inc.
|
|
|
1,250,000 |
|
|
|
2015-02-17 |
13G/A
|
XNCR / Xencor, Inc.
|
|
|
1,927,171 |
|
|
|
2015-02-17 |
13G
|
ADYX / Adynxx, Inc.
|
|
|
1,121,951 |
|
|
|
2015-02-17 |
13G
|
NEPT / Neptune Wellness Solutions Inc.
|
|
|
6,750,444 |
|
|
|
2015-02-17 |
13G/A
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
2,812,352 |
|
|
|
2015-02-17 |
13G
|
MGCD / MGC Diagnostics Corp.
|
|
|
336,287 |
|
|
|
2015-02-17 |
13G
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
3,214,549 |
|
|
|
2015-02-17 |
13G
|
GNVC / GenVec, Inc.
|
|
|
1,040,344 |
|
|
|
2014-06-03 |
13G
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
8,339,444 |
|
|
|
2014-02-14 |
13G/A
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
350,000 |
|
|
|
2014-02-14 |
13G
|
XNCR / Xencor, Inc.
|
|
|
1,568,672 |
|
|
|
2014-02-14 |
13G/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
447,785 |
|
|
|
2014-02-14 |
13G/A
|
ATHX / Athersys, Inc.
|
|
|
1,700,887 |
|
|
|
2014-02-14 |
13G/A
|
ACRX / Talphera, Inc.
|
|
|
6,574,060 |
|
|
|
2014-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
35,248,555 |
|
|
|
2014-02-14 |
13G
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
3,552,512 |
|
|
|
2014-02-14 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
3,960,737 |
|
|
|
2013-03-21 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
812,560 |
|
|
|
2013-02-14 |
13G/A
|
CSU / Capital Senior Living Corp.
|
|
|
1,211,469 |
|
|
|
2013-02-14 |
13G
|
INFI / Infinity Pharmaceuticals Inc.
|
|
|
2,544,739 |
|
|
|
2013-02-14 |
13G/A
|
HRTX / Heron Therapeutics, Inc.
|
|
|
31,504,199 |
|
|
|
2013-02-14 |
13G/A
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
4,212,137 |
|
|
|
2013-02-13 |
13G/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
2,748,426 |
|
|
|
2013-02-13 |
13G/A
|
ATHX / Athersys, Inc.
|
|
|
4,456,797 |
|
|
|
2012-12-13 |
13G
|
ACRX / Talphera, Inc.
|
|
|
5,008,400 |
|
|
|
2012-12-03 |
13G/A
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
2,698,426 |
|
|
|
2012-05-23 |
13G/A
|
76028H209 / Repros Therapeutics, Inc.
|
|
|
2,862,560 |
|
|
|
2012-02-10 |
13G
|
ATHX / Athersys, Inc.
|
|
|
1,456,797 |
|
|
|
2012-02-10 |
13G
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
1,253,354 |
|
|
|
2012-02-10 |
13G
|
|
|
|
350,000 |
|
|
|
2012-02-10 |
13G
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
3,323,390 |
|
|
|